The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Between 2026 And 2030?
The market size for advanced therapy medicinal products contract development and manufacturing organizations (CDMOs) has experienced rapid expansion in recent years. It is projected to increase from $6.2 billion in 2025 to $7.24 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth has been driven by factors such as the limited availability of specialized CDMO services, growing R&D investment in advanced therapies, the early adoption of gene and cell therapies, an increase in the prevalence of complex diseases, and the emergence of small biotech startups.
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $12.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. This projected growth during the forecast period is driven by factors such as advancements in scalable manufacturing technologies, increasing partnerships between CDMOs and pharmaceutical companies, the expanding adoption of autologous and allogeneic therapies, a global surge in demand for personalized medicine, and market penetration into developing regions. Key developments anticipated over this period encompass a heightened demand for CDMO services in advanced therapy creation, the broadening scope of gene, cell, and tissue-engineered therapies, an intensified focus on adhering to regulatory standards and quality benchmarks, an increase in outsourced manufacturing for biopharmaceutical entities, and the integration of adaptable and scalable manufacturing platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The rising number of clinical trials is anticipated to drive the expansion of the advanced therapy medicinal products CDMO market going forward. These trials are research studies performed in humans to evaluate the safety and effectiveness of medical interventions such as drugs, treatments, devices, or preventive measures. The quantity of clinical trials is increasing to satisfy the growing need for innovative treatments and to address an expanding global disease burden. The utilization of advanced therapy medicinal products consequently boosts the demand for CDMO manufacturing services, leveraging specialized expertise and infrastructure. Data from clinical trials assists in optimizing manufacturing, ensuring scalability, and maintaining quality to meet broader clinical and commercial requirements. For instance, in July 2024, the Royal Pharmaceutical Society, a professional membership body based in the UK, stated that 349,019 people were recruited to clinical trials in the UK in 2023/2024, an increase from 342,390 people in 2022/2023. Thus, the increasing number of clinical trials is propelling the growth of the advanced therapy medicinal products CDMO market.
How Are Segments Identified Within The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segment Framework?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs
Which Trends Are Influencing Demand In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Leading companies in the advanced therapy medicinal products CDMO market are developing sophisticated cell therapy manufacturing services. This initiative aims to resolve significant issues in cell therapy production and accelerate the development activities of their partners. These cell therapy manufacturing services, provided by contract development and manufacturing organizations, cover a spectrum of offerings from early preclinical development through late-stage clinical trials and eventual commercialization. For example, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company that transforms cells into solutions, inaugurated PluriCDMO, a new business division focused on offering cell therapy manufacturing. This division utilizes a patented bioreactor system that enables 3D cell multiplication, facilitating the production of various cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO intends to supply high-quality, crucial medicines to patients while ensuring distinct batch-to-batch consistency in a scalable and cost-effective manner within good manufacturing practice settings.
Who Are The Companies Competing Within The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Get The Full Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report:
Which Region Holds The Highest Market Share In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model